Target intelligence / Profile preview

RNASEH1 divergent transcript (RNASEH1-DT)

Target
RNASEH1-DT
Molecular classification
Other, long non-coding RNA
01

Overview

RNASEH1-DT (RNASEH1 divergent transcript) is a long non-coding RNA gene transcribed from the antisense strand near the RNASEH1 locus. RNASEH1-DT is thought to have a regulatory role in the expression of the RNASEH1 gene, though its functional significance is poorly understood. It does not encode an enzyme or receptor and is not a classical druggable target. The RNASEH1 gene itself encodes ribonuclease H1, an enzyme involved in the degradation of RNA in RNA-DNA hybrids and plays a critical role in DNA replication, repair, and mitochondrial function, but the divergent transcript (RNASEH1-DT) is distinct—functioning potentially as an RNA regulator rather than a protein[1][3]. The clinical and biological roles of RNASEH1-DT remain to be defined in scientific literature. Key distinction: RNASEH1-DT is a long non-coding RNA; it is different from RNASEH1 (Ribonuclease H1), which is a catalytic enzyme with well-defined biological and disease roles[3]. There is no evidence that RNASEH1-DT itself is a direct therapeutic target, nor that it interacts with drugs. It primarily serves as a locus for antisense transcription that may regulate the adjacent RNASEH1 gene.

Other names
LOC100506054RNASEH1-AS1RNASEH1 antisense RNA 1RNASEH1-DT
02

Biological functions

Regulatory RNApotential involvement in regulating RNASEH1 gene expressionspecific functions are not well characterized
03

Disease associations

Otherno well-established direct roles in disease

Beyond the preview

Go deeper on RNASEH1 divergent transcript (RNASEH1-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNASEH1 divergent transcript (RNASEH1-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call